Elanco Animal Health Q3 2024 10-Q Filing
Ticker: ELAN · Form: 10-Q · Filed: 2024-11-07T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, financials
TL;DR
Elanco Animal Health filed its Q3 2024 10-Q, detailing financial performance for the period ending Sept 30.
AI Summary
Elanco Animal Health Inc. reported its financial results for the period ending September 30, 2024. The company's filing covers the third quarter of 2024, detailing its financial performance and position. Specific financial figures and operational details for this period are outlined within the report.
Why It Matters
This filing provides investors with a detailed look at Elanco's financial health and operational performance during the third quarter of 2024, influencing investment decisions.
Risk Assessment
Risk Level: medium — 10-Q filings inherently carry medium risk due to the detailed financial data and potential for market-moving information.
Key Players & Entities
- Elanco Animal Health Inc (company) — Filer
- 2024-09-30 (date) — Period End Date
- 2024-11-07 (date) — Filing Date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the period ended September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on November 7, 2024.
What is Elanco Animal Health Inc.'s Standard Industrial Classification code?
Elanco Animal Health Inc.'s Standard Industrial Classification code is 2834, Pharmaceutical Preparations.
What is the fiscal year end for Elanco Animal Health Inc.?
Elanco Animal Health Inc.'s fiscal year end is December 31.
What is the business phone number listed for Elanco Animal Health Inc.?
The business phone number listed for Elanco Animal Health Inc. is 877-352-6261.
From the Filing
0001739104-24-000039.txt : 20241107 0001739104-24-000039.hdr.sgml : 20241107 20241107090758 ACCESSION NUMBER: 0001739104-24-000039 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 241433458 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 10-Q 1 elan-20240930.htm 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2024 elan-20240930 false 2024 Q3 0001739104 --12-31 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure elan:employee elan:reporting_unit iso4217:CHF elan:executive 0001739104 2024-01-01 2024-09-30 0001739104 2024-11-04 0001739104 2024-07-01 2024-09-30 0001739104 2023-07-01 2023-09-30 0001739104 2023-01-01 2023-09-30 0001739104 2024-09-30 0001739104 2023-12-31 0001739104 us-gaap:CommonStockMember 2022-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2022-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001739104 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001739104 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001739104 us-gaap:RetainedEarningsMember 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001739104 2023-03-31 0001739104 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001739104 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001739104 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001739104 us-gaap:CommonStockMember 2023-06-30 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001739104 us-gaap:RetainedEarningsMember 2023-06-30 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001739104 2023-06-30 0001739104 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-07-01 2023-09-30 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-07-01 2023-09-30 0001739104 us-gaap